Skip to content

Study on technical specification and curative effect evaluation of warming lung and guyuan umbilical moxibustion for chronic obstructive pulmonary disease

Study on technical specification and curative effect evaluation of warming lung and guyuan umbilical moxibustion for chronic obstructive pulmonary disease

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2100049802
Enrollment
Unknown
Registered
2021-08-09
Start date
2021-08-15
Completion date
Unknown
Last updated
2022-04-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic obstructive pulmonary disease

Interventions

Sponsors

The First Affiliated Hospital of Henan University of Chinese Medicine
Lead Sponsor

Eligibility

Sex/Gender
All
Age
40 Years to 80 Years

Inclusion criteria

Inclusion criteria: 1. Patients with stable COPD diagnosis; 2. Aged 40 to 80 years; 3. Patients with qi deficiency syndrome (lung qi deficiency, lung spleen deficiency, lung and kidney qi deficiency); 4. The number of acute exacerbations in the previous year >= 1; 5. Not participating in clinical studies of other interventions within 1 month before enrollment; 6. Able to tolerate lung-warming and solid-element umbilical moxibustion therapy; 7. Voluntarily accept the treatment and sign the informed consent.

Exclusion criteria

Exclusion criteria: 1. Pregnant and lactating women; 2. Confused, dementia, various mentally ill patients; 3. Combined with severe cardiac insufficiency; 4. Patients with active pulmonary tuberculosis, diffuse panbronchiolitis, pneumothorax, pleural effusion, and pulmonary embolism; 5. Combined with neuromuscular diseases affecting respiratory and motor function; 6. Combined tumor; 7. Severe liver and kidney disease (ALT/AST>=3 times normal value, glomerular filtration rate GFR<=29); 8. Those who are known to be allergic to the composition of moxibustion powder.

Design outcomes

Primary

MeasureTime frame
Number and severity of chronic obstructive pulmonary disease acute exacerbations;

Secondary

MeasureTime frame
Clinical symptoms and signs;Dyspnea classification;6 minutes walking distance;Quality of life;Patient Reported Outcome;Effectiveness satisfaction questionnaire;Lung function;Evaluation of skin sensitization;

Countries

China

Contacts

Public ContactWang Minghang

The First Affiliated Hospital of Henan University of Chinese Medicine

wmh107hn@163.com+86 18638392188

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026